up 78%, page-2

worth a look Ferret's Stock to Watch: MEDEC LIMITED
07:45, Thursday, 17 February 2005

HEALTH CARE COMPANY MEASURING ENERGY IN THE HUMAN BODY

Sydney - Thursday - February 17: (RWE)
**************************************

OVERVIEW
********

A biotech company called Medec Ltd has made its presence felt in
the past week with a share placement and the disclosure that the company
has become cash flow positive in the last quarter of 2004.
Medec yesterday attracted attention after announcing a placement
of 5 million shares at various prices in Germany and the listing of its
stock on the Berlin/Bremen Stock Exchange.
Trading began briskly on the German boerse with more than a
million shares traded during the past few days.
Medec is described as a Perth based health care equipment
company.
It operates in the research and development of field energy
medicine and provides equipment and services for monitoring and
stimulating the energy of the human body.
The company's primary products are the Medec Biograph,
the Medec Bioresonance System and the Medec Pulse.
The Medec Biograph is a combination of traditional Chinese
meridian energy philosophy and computer based information technology.
The device is a diagnostic tool for the application of energy
monitoring and therapycontrol in clinical and experimental medicine.

Its capabilities include the measurement and recording of the
biological energy levels of a person in a 10-minute diagnosis.
In a media release yesterday the company told the Australian
Stock Exchange that it has increased its revenue from $2 million in 2003
to $6 million in the 2004 calendar year.
It expects a revenue flow of $12 million for the current year.
Medec says it is now finalising the various reasearch and
development projects outlined in the 2003 IPO prospectus and cash flow
has turned positive in the December quarter.
However, the launch of additional productgs and expected
continuous strong growth in 2006, may require additonal funds since
Medec's line of business is based on a trading stock of three months of
trading.
Following the German placement, VEM Investment Bank AG of Munich
has spread them into the German market.
Executive of chairman of Medec Mr Josef Plattner says the
placement gives the company access to German capital markets.
" We have two Medec subsidiaries in Germany and want to establish
several Medec/Athlegen showrooms which is developing into the hub of for
Medec's European activity," he revealed.
Athlegen is a subsidiary of Medec while Vitop is a partner in in
the South East Asian and China operations.


SHARE PRICE MOVEMENTS
*********************

Shares of Medic yesterday climbed 18.5c to 42c following the
latest news. Rolling high has been 42c and low 12c. The company has 18.6
shares on issue with a market cap of $7.8 million.

The product, Medec Bioresonance System, is claimed to be one of
the most advanced and revolutionary products on the complementary and
alternative health market.
Extensive research and numerous case studies have indicated the
Medec Bioresonance System may assist in the treatment and prevention of
illness and disease.
It has been used successfully in Perth, Western Australia over
the last 12 months and in Germany and Austria for many years.
The MEDEC Business Unit (MBU) has proven potential for great
cash-flow and profits.
It requires minimal administration, overheads and investment
considering the potential returns that can be earned.
An esoteric research program centres around traditional Chinese
medicine that believes that energy circulates around the body.
Moving muscles prove electric discharges in an electro magnetic
field.
In 1996 Dr W Ross Adey suggested that cells maintain their
organised society by "whispering together" in a faint and private
language.
These "whispers", travel both, as biochemical messages and
electromagnetic signals.
They reflect a deeper layer of communication , a more subtile
realm of interaction underlying the familiar language of nerve impulses
or the words spoken by molecules.
Mr Plattner says an adviser in this field is a Russian scientist
and former head of the Russian Medical Centre who watched over Russia's
astronauts.


BACKGROUND
**********

Medec was listed on the Australian Stock Exchange in October
2003.
It specialises in the development and growth of Energy Medicine,
party of a newly emerging sections of medical technology.
On an international level, Medec provides equipment and services
to measure, assess, stimulate and monitor the energy of the human body.
The core business of MEDEC is the development and sale of
advanced electronic products and systems for use in the field of health
care and energy medicine.
The products are based on a combination of scientific western,
traditional Chinese and complementary medical systems.
The Medec range of products includes the Medec Biograph, a high
technology diagnostic system.
It has many applications in early diagnosis and prevention of
disease, in energy monitoring and therapy control.
The Medec Bioresonance System stimulates the complete organism
inductively and regulates acupuncture points and meridians.
It is designed for private use at home, but it is also
increasingly used and supported by doctors, medical institutions and high
profile professional athletes.
The Medec group of companies and its subsidiaries has several
product ranges, including the award winning Athlegen brand, which is
claimed to be Australia's market leader in treatement tables for the
wellness industry and the innovative MEDEC energy medicine products.
Medec's major market at present is Europe with two subsidiaries
and 25 distribution outlets, USA with 8 outlets and Australia with 8.
Medec/Athlegen operates in show rooms in all Caautralian capital
cities was well as in Malaysia and Germany.
Fourteen international distributors sell the products to the
wellness and health industry and 50 international franchiseesoffer the
health stimulating products to the public which are sold in 30 countries.
Focus of market expansion is presently on South East Asia, Europe
and now China.
ENDS